Contribution: Industrial Research Assistance Program – Contributions to Firms
BioLytical Laboratories Inc.
$50,000.00
Development and Evaluation of Aptamers Against the Hepatitic C Virus Core Protein
EF 2018-19 · 2018-07-01
Résumé
Aptamers are DNA or RNA constructs designed to specifically bind to a desired target. This project is designed to develop aptamers that target the HCV Core protein and perform initial analyses to determine if aptamers can be used in future rapid diagnostic test kits.
Ministère
Programme
Industrial Research Assistance Program – Contributions to FirmsIndustrial Research Assistance Program-Contributions to Firms (lien de confiance élevée)
Bénéficiaire
Emplacement
Richmond|Richmond, British Columbia, Canada
Type de bénéficiaire
For-profit organization
Numéro d'entreprise
869859116
Type
Contribution
Source
Proactive Disclosure - Grants and Contributions
Modifications
Chaque version de l'entente telle que publiée, de la plus ancienne à la plus récente, avec son total à cette version. Le montant ci-dessus est le plus récent.
| Modification | Date | Exercice financier | Total |
|---|---|---|---|
| 1 | 2018-07-01 | 2018-19 | $50,000.00 |
| 2 | 2018-07-01 | 2018-19 | $50,000.00 |
Tel que publié
Additional Information
This agreement has been amended 1 time(s). The end date of this agreements has been modified by 74 days.
Additional Information (French)
Cet accord a été modifié 1 fois La date de fin du présent accord a été changé de 74 jours.
Agreement End Date
2019-03-15
Agreement Number
910621
Agreement Start Date
2018-07-01
Agreement Title
Development and Evaluation of Aptamers Against the Hepatitic C Virus Core Protein
Agreement Title (French)
Développement et évaluation des aptamères contre la protéine centrale du virus hépatite C
Agreement Type
Contribution
Agreement Value
$50,000.00
Amendment Date
2018-12-06
Amendment Number
2
Coverage
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation. | Les projets des Contributions aux entreprises stimulent la création de richesse au Canada grâce à l’innovation technologique.
Description
Aptamers are DNA or RNA constructs designed to specifically bind to a desired target. This project is designed to develop aptamers that target the HCV Core protein and perform initial analyses to determine if aptamers can be used in future rapid diagnostic test kits.
Description (French)
Développement et évaluation des aptamères contre la protéine centrale du virus hépatite C
Expected Results
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Expected Results (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Federal Riding
Steveston--Richmond East
Federal Riding (French)
Steveston--Richmond-Est
Federal Riding Number
59031
NAICS Code
334512
Organization Code
nrc-cnrc
Organization
National Research Council Canada | Conseil national de recherches Canada
Program Name
Industrial Research Assistance Program – Contributions to Firms
Program Name (French)
Programme d’aide à la recherche industrielle – Contributions aux entreprises
Program Purpose
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Program Purpose (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Recipient Business Number
869859116
Recipient City
Richmond|Richmond
Recipient Country
CA
Recipient Legal Name
BioLytical Laboratories Inc.
Recipient Postal Code
V6V 2X7
Recipient Province or Territory
BC
Recipient Type
F
Reference Number
172-2018-2019-Q2-910621
